• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[法尼醇醋酸泼尼松龙(PNF)凝胶对比格犬的52周经皮毒性研究及8周恢复期]

[A 52-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 8 weeks].

作者信息

Nagashima Y, Ide M, Akai H, Tamura K, Shimura K, Tanaka H, Tanaka G

机构信息

Bozo Research Center Inc., Tokyo, Japan.

出版信息

J Toxicol Sci. 1992 Nov;17 Suppl 3:161-99. doi: 10.2131/jts.17.supplementiii_161.

DOI:10.2131/jts.17.supplementiii_161
PMID:1293322
Abstract

The toxicity of Prednisolone farnesylate (PNF) gel, a synthetic glucocorticoid, was investigated in the Beagle dog. PNF gel was administered percutaneously at doses of 0.05, 0.2 and 0.8 mg/kg/day for 52 weeks, then the drug was with held for 8 weeks to evaluate reversibility. The results are summarized in the following. 1. In the 0.05 mg/kg/day and above groups, hypotrichosis in the application site of the skin, thinning of the skin and atrophy of the appendages, and in the 0.2 mg/kg/day and above groups a tendency toward retarded body weight gain, were observed. 2. In the 0.2 mg/kg/day and above groups, a drop in the lymphocyte ratio, a rise in GOT activity and A1P level, and in the 0.8 mg/kg/day group a rise in free fatty acid were observed. 3. In the 0.2 mg/kg/day group and above groups, atrophy of the zona fasciculata and zona reticularis were observed. In the 0.8 mg/kg/day group, a decrease in the weight of the thymus and adrenal glands, and a increase in the weight of the liver, were observed. 4. At the end of the recovery period, most of the changes disappeared, except for those in the adrenals and treated area. From the above results, under the conditions of this study, it was concluded that when the changes observed in the application site of the skin in each group were not taken into consideration, the toxicological no effect level was 0.05 mg/kg/day for both males and females and the overt toxic dose level was 0.8 mg/kg/day.

摘要

对一种合成糖皮质激素法尼醇泼尼松龙(PNF)凝胶在比格犬身上进行了毒性研究。以0.05、0.2和0.8mg/kg/天的剂量经皮给予PNF凝胶,持续52周,然后停药8周以评估可逆性。结果总结如下:1. 在0.05mg/kg/天及以上剂量组,观察到皮肤涂抹部位脱毛、皮肤变薄和附属器萎缩;在0.2mg/kg/天及以上剂量组,观察到体重增加有减缓趋势。2. 在0.2mg/kg/天及以上剂量组,观察到淋巴细胞比例下降、谷草转氨酶(GOT)活性和碱性磷酸酶(A1P)水平升高;在0.8mg/kg/天剂量组,观察到游离脂肪酸升高。3. 在0.2mg/kg/天及以上剂量组,观察到束状带和网状带萎缩。在0.8mg/kg/天剂量组,观察到胸腺和肾上腺重量减轻,肝脏重量增加。4. 在恢复期结束时,除肾上腺和治疗部位外,大多数变化消失。从上述结果得出,在本研究条件下,若不考虑各组皮肤涂抹部位观察到的变化,雄性和雌性的毒理学无作用水平均为0.05mg/kg/天,明显中毒剂量水平为0.8mg/kg/天。

相似文献

1
[A 52-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 8 weeks].[法尼醇醋酸泼尼松龙(PNF)凝胶对比格犬的52周经皮毒性研究及8周恢复期]
J Toxicol Sci. 1992 Nov;17 Suppl 3:161-99. doi: 10.2131/jts.17.supplementiii_161.
2
[A 13-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 5 weeks].
J Toxicol Sci. 1992 Nov;17 Suppl 3:123-60. doi: 10.2131/jts.17.supplementiii_123.
3
[A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks].[法尼醇泼尼松龙(PNF)凝胶对大鼠的52周皮肤毒性研究及8周恢复期]
J Toxicol Sci. 1992 Nov;17 Suppl 3:91-122. doi: 10.2131/jts.17.supplementiii_91.
4
[A 13-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 5 weeks].[泼尼松龙法尼酯(PNF)凝胶对大鼠的13周皮肤毒性研究及5周恢复期]
J Toxicol Sci. 1992 Nov;17 Suppl 3:49-89. doi: 10.2131/jts.17.supplementiii_49.
5
[A 13-week subcutaneous toxicity study of prednisolone farnesylate (PNF) in rats].[泼尼松龙法尼酯(PNF)对大鼠的13周皮下毒性研究]
J Toxicol Sci. 1992 Nov;17 Suppl 3:1-48. doi: 10.2131/jts.17.supplementiii_1.
6
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF prior to and in the early stages of pregnancy in rats].法尼醇泼尼松龙(PNF)的生殖与发育毒性研究——大鼠孕期前及孕早期皮下注射PNF的研究
J Toxicol Sci. 1992 Nov;17 Suppl 3:201-15. doi: 10.2131/jts.17.supplementiii_201.
7
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--teratogenicity study in rabbits by subcutaneous administration].[法呢酸泼尼松龙(PNF)的生殖与发育毒性研究——家兔皮下给药致畸性研究]
J Toxicol Sci. 1992 Nov;17 Suppl 3:241-50. doi: 10.2131/jts.17.supplementiii_241.
8
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study of subcutaneous administration of PNF during the perinatal and lactation periods in rats].法尼醇醋酸泼尼松龙的生殖与发育毒性研究——大鼠围产期及哺乳期皮下注射法尼醇醋酸泼尼松龙的研究
J Toxicol Sci. 1992 Nov;17 Suppl 3:251-67. doi: 10.2131/jts.17.supplementiii_251.
9
[Effects of prednisolone farnesylate (PNF) gel on skin and ocular mucosa].[法呢醇醋酸泼尼松龙(PNF)凝胶对皮肤和眼黏膜的影响]
J Toxicol Sci. 1992 Nov;17 Suppl 3:283-312. doi: 10.2131/jts.17.supplementiii_283.
10
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF during the period of fetal organogenesis in rats].法尼醇醋酸泼尼松龙的生殖与发育毒性研究——大鼠胎儿器官形成期皮下注射法尼醇醋酸泼尼松龙的研究
J Toxicol Sci. 1992 Nov;17 Suppl 3:217-39. doi: 10.2131/jts.17.supplementiii_217.

引用本文的文献

1
Histological dermal changes caused by preparation and application procedures in percutaneous dose toxicity studies in dogs, rabbits and rats.犬、兔和大鼠经皮剂量毒性研究中制备和应用程序引起的组织学皮肤变化。
J Toxicol Pathol. 2015 Jan;28(1):1-9. doi: 10.1293/tox.2014-0021. Epub 2014 Aug 8.